Metabolic syndrome and cognitive function in Midlife

23Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective: Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors associated with cognitive decline. We investigated the relationship between MetS and cognition in middle-aged adults. We hypothesized that higher numbers of MetS components will relate to poorer performance on executive function (EF) tasks as frontal lobe regions critical to EF are particularly vulnerable to cardiovascular disease. Methods: 197 adults (ages 40-60) participated. MetS was evaluated using established criteria. Composite scores for cognitive domains were computed as follows: Global cognitive function (subtests from the Wechsler Abbreviated Scale of Intelligence, 2nd Edition), EF (Stroop Color Word, Digit Span Backward, and Trails A and B), and memory (California Verbal Learning Test, 2 Edition). Results: Higher number of MetS components was related to weaker EF - F(4, 191) = 3.94, p =. 004, MetS components ß = -.14, p =. 044. A similar relationship was detected for tests of memory - F(4, 192) = 7.86, p

Cite

CITATION STYLE

APA

Foret, J. T., Oleson, S., Hickson, B., Valek, S., Tanaka, H., & Haley, A. P. (2021). Metabolic syndrome and cognitive function in Midlife. Archives of Clinical Neuropsychology, 36(6), 897–907. https://doi.org/10.1093/arclin/acaa112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free